Anyone else nervous that compounded semaglutide may end soon: what to track and how to measure progress

Why the Anxiety Around Compounded Semaglutide Is Valid

As a 52-year-old woman managing diabetes, blood pressure, and stubborn midsection weight that worsened through perimenopause, I understand the fear that compounded semaglutide could vanish. The FDA’s recent moves on compounding pharmacies have left many of us feeling exposed after finally finding something that works when every prior diet failed. The good news? You can build lasting habits now that protect your progress regardless of medication access.

In my book The CFP Method: Sustainable Weight Loss After 45, I emphasize shifting from quick-fix panic to measurable, hormone-friendly systems. Compounded semaglutide suppresses appetite and slows gastric emptying, but its exit doesn’t have to mean weight regain if you track the right biomarkers and behaviors.

Key Metrics to Track While You Still Have Access

Don’t just weigh yourself. Measure these four areas weekly:

• Body composition: Use a smart scale or DEXA scan every 4-6 weeks to track fat mass versus muscle. Aim to lose no more than 1-2 pounds of fat per week while preserving lean mass—critical when joint pain already limits movement.
• Blood markers: Monitor fasting glucose, A1C, fasting insulin, and CRP. Many see A1C drop 1.5-2 points and blood pressure improve 10-15 mmHg within 3 months on semaglutide. Log these to prove medical necessity if insurance ever covers alternatives.
• Non-scale victories: Record daily energy, joint pain on a 1-10 scale, clothing fit, and average daily steps. My clients often report 40% less knee pain once they lose 8-10% body weight.
• Food and hormone response: Track protein intake (target 1.2g per kg of ideal body weight), fiber (35g+ daily), and how meals affect cravings. This reveals your unique metabolic pattern as estrogen declines.

How to Measure Real Progress That Lasts

Use my CFP Progress Score: assign 0-10 points weekly across Consistency (meal timing), Fuel (protein + fiber targets), and Patience (stress and sleep metrics). A score above 24/30 predicts maintenance success even after stopping compounded semaglutide. Photograph your waist weekly under consistent lighting—visceral fat reduction often shows here before the scale moves.

Prepare for transition by slowly tapering while increasing resistance training 2-3 times weekly using bodyweight or bands. This combats the muscle loss risk that comes with rapid weight reduction and hormonal shifts. Focus on 20-minute strength sessions that fit busy schedules—no gym intimidation required.

Building a Future-Proof Plan Beyond the Medication

The real win is using this window to rewire habits. Prioritize sleep (7-9 hours), manage stress through 10-minute walks after meals, and create simple 5-ingredient meal templates. Many women in our program maintain 80% of their loss by continuing these practices post-GLP-1. If compounded semaglutide ends, explore FDA-approved alternatives through your doctor or pivot fully to the CFP Method’s food-first approach that addresses insulin resistance directly.

Start tracking today. Your data becomes your confidence when the medication landscape changes. Thousands of women aged 45-55 have used these exact measurements to break the cycle of failed diets and reclaim control despite joint pain, hormonal chaos, and time constraints.